These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 12951354)

  • 1. Treatment and outcome of Pseudomonas aeruginosa bacteraemia: an antibiotic pharmacodynamic analysis.
    Zelenitsky SA; Harding GK; Sun S; Ubhi K; Ariano RE
    J Antimicrob Chemother; 2003 Oct; 52(4):668-74. PubMed ID: 12951354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudomonas aeruginosa bacteraemia. Is pancreatobiliary disease a risk factor?
    Chen SC; Lawrence RH; Byth K; Sorrell TC
    Med J Aust; 1993 Nov; 159(9):592-7. PubMed ID: 8232033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology and clinical outcomes of patients with multiresistant Pseudomonas aeruginosa.
    Harris A; Torres-Viera C; Venkataraman L; DeGirolami P; Samore M; Carmeli Y
    Clin Infect Dis; 1999 May; 28(5):1128-33. PubMed ID: 10452647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology and outcome of Pseudomonas aeruginosa bacteremia, with special emphasis on the influence of antibiotic treatment. Analysis of 189 episodes.
    Vidal F; Mensa J; Almela M; Martínez JA; Marco F; Casals C; Gatell JM; Soriano E; Jimenez de Anta MT
    Arch Intern Med; 1996 Oct; 156(18):2121-6. PubMed ID: 8862105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevention and antibiotic treatment of Pseudomonas aeruginosa septicemia].
    Deng GH
    Zhonghua Yi Xue Za Zhi; 1993 Oct; 73(10):599-601, 637. PubMed ID: 8313182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamic modeling of risk factors for ciprofloxacin resistance in Pseudomonas aeruginosa.
    Hyatt JM; Schentag JJ
    Infect Control Hosp Epidemiol; 2000 Jan; 21(1 Suppl):S9-11. PubMed ID: 10654629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic in vitro and in vivo activities of ampicillin and aminoglycoside combinations against antibiotic-resistant Pseudomonas aeruginosa strains.
    Elkhouly AE; el-Sokkary MA; el-Emam MA
    Chemioterapia; 1987 Jun; 6(2 Suppl):125-8. PubMed ID: 3151331
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro susceptibility of aural isolates of Pseudomonas aeruginosa to commonly used ototopical antibiotics.
    Dohar JE; Kenna MA; Wadowsky RM
    Am J Otol; 1996 Mar; 17(2):207-9. PubMed ID: 8723948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacterial and host factors affecting Pseudomonas aeruginosa colonization versus bacteremia in granulocytopenic patients.
    Dick JD; Shull V; Karp JE; Valentine J
    Eur J Cancer Clin Oncol; 1988; 24 Suppl 1():S47-54. PubMed ID: 3127218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined aztreonam and gentamicin therapy for pseudomonal lower respiratory tract infections.
    Andrews R; Fasoli R; Scoggins WG; Algozzine GJ; Spann RW; Sundaresh KV; Mathers JA; Babb R; Kuppinger M; Cooper B
    Clin Ther; 1994; 16(2):236-52. PubMed ID: 8062319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Loss of antibiotic sensitivity of Pseudomonas aeruginosa strains during treatment].
    López-Yeste ML; Chaves J; Garau J; Martín A; Tirado M; Reig R; Roy C
    Med Clin (Barc); 1994 Jun; 103(3):81-4. PubMed ID: 8065221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bacteremia with granulocytopenia--microbiology and empiric antibiotic treatment].
    Hammerstrøm J; Jacobsen T
    Tidsskr Nor Laegeforen; 1998 Nov; 118(28):4370-5. PubMed ID: 9889610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Infection by Pseudomonas aeruginosa in patients with human immunodeficiency virus infection. Descriptive study of 35 cases].
    Elvira J; López-Suárez A; Clavo A; Piña JM; Segura E; Pérez-Guzmán E; Girón JA
    Enferm Infecc Microbiol Clin; 1998; 16(7):322-7. PubMed ID: 9808882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of pharmacokinetic indices with therapeutic outcome in patients receiving aminoglycosides.
    Deziel-Evans LM; Murphy JE; Job ML
    Clin Pharm; 1986 Apr; 5(4):319-24. PubMed ID: 3709080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aminoglycoside adaptive resistance.
    Karlowsky JA; Zelenitsky SA; Zhanel GG
    Pharmacotherapy; 1997; 17(3):549-55. PubMed ID: 9165557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudomonas aeruginosa endocarditis. A report of nine cases.
    Witchitz S; Gibert C; Witchitz J; Gougerot M; Vachon F; Vic-Dupont V
    Eur J Cardiol; 1976 Mar; 4(1):91-7. PubMed ID: 816657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bacteremia caused by Pseudomonas aeruginosa in patients with AIDS].
    Bouza Santiago E; Blázquez Garrido R; Rodríguez-Creixems M; Moreno Guillén S; Miralles Martín P; Alonso Fernández R
    Rev Clin Esp; 1996 Oct; 196(10):698-702. PubMed ID: 9005473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ventilator-associated pneumonia caused by Pseudomonas infection.
    Dunn M; Wunderink RG
    Clin Chest Med; 1995 Mar; 16(1):95-109. PubMed ID: 7768096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Netilmicin in the treatment of Pseudomonas bacteremia.
    Lorber RR; Linzmayer MI
    Clin Ther; 1985; 7(3):338-46. PubMed ID: 3922616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of infectious diseases consultation on the management and outcomes of Pseudomonas aeruginosa bacteraemia in adults: a retrospective cohort study.
    Chiong F; Wasef MS; Liew KC; Cowan R; Tsai D; Lee YP; Croft L; Harris O; Gwini SM; Athan E
    BMC Infect Dis; 2021 Jul; 21(1):671. PubMed ID: 34243714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.